Oncology Research International Limited ORIL
Overview
Australian drug discovery company that has discovered and developed range of plant-based compounds having novel mode of anti-cancer action. Currently undergoing pre-clinical studies in readiness for Phase I study in early 2013.
Main business focus/
Listing by sector:
- Drug Discovery & Development
- Oncology
Competitive Advantages
Natural plant-based compounds with demonstrated, novel mode of action against wide range of cancers.
Technology/IP
Patent family at various stags of evaluation and approval in major jurisdictions. IP portfolio includes novel synthesis, new analogues and application (anti-cancer and anti-angiogenesis).
Corporate Alliances/Partnerships
Public, unlisted company.
Partnering Opportunities
Seeking longer term strategic alliance
Partnering Needs
Financial support for Phase II and beyond
Contact Details
| Contact person | Dr Philip Marshall |
|---|---|
| Job Title | CEO |
| Address | 31 Seaview Road |
| City/Suburb | Tennyson |
| State | South Australia |
| Operating State | Western Australia |
| pharmche@ozemail.com.au | |
| Phone | +618 8355 6023 +61(0)401 657 477 |
| Website | http://www.oril.com.au |
